HEADER MEMBRANE PROTEIN, CELL INVASION 04-DEC-13 4NUV TITLE HETEROTETRAMER STRUCTURE OF REGION II FROM PLASMODIUM VIVAX DUFFY TITLE 2 BINDING PROTEIN (PVDBP) BOUND TO THE ECTODOMAIN OF THE DUFFY ANTIGEN TITLE 3 RECEPTOR FOR CHEMOKINES (DARC) COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUFFY RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 211-525; COMPND 5 SYNONYM: ERYTHROCYTE-BINDING PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: DUFFY ANTIGEN/CHEMOKINE RECEPTOR; COMPND 9 CHAIN: C, D; COMPND 10 FRAGMENT: UNP RESIDUES 14-43; COMPND 11 SYNONYM: ATYPICAL CHEMOKINE RECEPTOR 1, FY GLYCOPROTEIN, GPFY, COMPND 12 GLYCOPROTEIN D, PLASMODIUM VIVAX RECEPTOR; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM VIVAX; SOURCE 3 ORGANISM_TAXID: 126793; SOURCE 4 STRAIN: SALVADOR I; SOURCE 5 GENE: PVDR; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: DARC, ACKR1, FY, GPD; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DUFFY BINDING LIKE (DBL) DOMAIN FOLD, GPCR, ADHESION, INVASION, RED KEYWDS 2 BLOOD CELL BINDING, CHEMOKINE BINDING, DUFFY ANTIGEN RECEPTOR FOR KEYWDS 3 CHEMOKINES, MEMBRANE, MEMBRANE PROTEIN, PROTEIN BINDING, CELL KEYWDS 4 INVASION EXPDTA X-RAY DIFFRACTION AUTHOR N.H.TOLIA REVDAT 4 13-MAR-24 4NUV 1 SOURCE REVDAT 3 20-SEP-23 4NUV 1 REMARK SEQADV REVDAT 2 22-NOV-17 4NUV 1 REMARK REVDAT 1 05-FEB-14 4NUV 0 JRNL AUTH J.D.BATCHELOR,B.M.MALPEDE,N.S.OMATTAGE,G.T.DEKOSTER, JRNL AUTH 2 K.A.HENZLER-WILDMAN,N.H.TOLIA JRNL TITL RED BLOOD CELL INVASION BY PLASMODIUM VIVAX: STRUCTURAL JRNL TITL 2 BASIS FOR DBP ENGAGEMENT OF DARC. JRNL REF PLOS PATHOG. V. 10 03869 2014 JRNL REFN ISSN 1553-7366 JRNL PMID 24415938 JRNL DOI 10.1371/JOURNAL.PPAT.1003869 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.90 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 22121 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1085 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 19.9048 - 5.1572 0.93 2584 137 0.1748 0.2387 REMARK 3 2 5.1572 - 4.1052 0.95 2622 135 0.1586 0.2027 REMARK 3 3 4.1052 - 3.5898 0.94 2605 137 0.1675 0.1894 REMARK 3 4 3.5898 - 3.2631 0.96 2669 131 0.1836 0.2487 REMARK 3 5 3.2631 - 3.0301 0.97 2674 126 0.1939 0.2710 REMARK 3 6 3.0301 - 2.8520 0.98 2672 145 0.2097 0.2713 REMARK 3 7 2.8520 - 2.7095 0.96 2651 143 0.2386 0.2759 REMARK 3 8 2.7095 - 2.5918 0.92 2559 131 0.2747 0.3392 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.690 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 5232 REMARK 3 ANGLE : 0.543 7030 REMARK 3 CHIRALITY : 0.034 732 REMARK 3 PLANARITY : 0.002 893 REMARK 3 DIHEDRAL : 11.861 2020 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4NUV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-DEC-13. REMARK 100 THE DEPOSITION ID IS D_1000083684. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-11 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 4.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK MONOCHROMATOR 1: REMARK 200 HIGH-RESOLUTION DOUBLE-CRYSTAL REMARK 200 SAGITTAL FOCUSING, ROSENBAUM- REMARK 200 ROCK MONOCHROMATOR 2: DOUBLE REMARK 200 CRYSTAL, ROSENBAUM-ROCK VERTICAL REMARK 200 FOCUSING MIRROR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NOIR-1 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22139 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.70 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3RRC REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.35 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES AND 20% (W/V) POLYETHYLENE REMARK 280 GLYCOL 6000, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 290K, PH REMARK 280 7.4 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1490 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16010 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 209 REMARK 465 SER A 210 REMARK 465 ASN A 255 REMARK 465 ASN A 256 REMARK 465 THR A 257 REMARK 465 ASP A 258 REMARK 465 THR A 259 REMARK 465 ASN A 260 REMARK 465 LYS A 370 REMARK 465 GLY A 371 REMARK 465 ASN A 372 REMARK 465 VAL A 466 REMARK 465 VAL A 509 REMARK 465 GLU A 510 REMARK 465 GLU A 511 REMARK 465 ALA A 512 REMARK 465 LYS A 513 REMARK 465 LYS A 514 REMARK 465 ASN A 515 REMARK 465 THR A 516 REMARK 465 GLN A 517 REMARK 465 GLU A 518 REMARK 465 VAL A 519 REMARK 465 VAL A 520 REMARK 465 THR A 521 REMARK 465 ASN A 522 REMARK 465 VAL A 523 REMARK 465 ASP A 524 REMARK 465 ASN A 525 REMARK 465 ALA B 209 REMARK 465 SER B 210 REMARK 465 ASN B 211 REMARK 465 THR B 212 REMARK 465 VAL B 213 REMARK 465 ASN B 255 REMARK 465 ASN B 256 REMARK 465 THR B 257 REMARK 465 ASP B 258 REMARK 465 THR B 259 REMARK 465 ASN B 260 REMARK 465 PHE B 261 REMARK 465 VAL B 509 REMARK 465 GLU B 510 REMARK 465 GLU B 511 REMARK 465 ALA B 512 REMARK 465 LYS B 513 REMARK 465 LYS B 514 REMARK 465 ASN B 515 REMARK 465 THR B 516 REMARK 465 GLN B 517 REMARK 465 GLU B 518 REMARK 465 VAL B 519 REMARK 465 VAL B 520 REMARK 465 THR B 521 REMARK 465 ASN B 522 REMARK 465 VAL B 523 REMARK 465 ASP B 524 REMARK 465 ASN B 525 REMARK 465 GLY C 10 REMARK 465 PRO C 11 REMARK 465 THR C 12 REMARK 465 GLY C 13 REMARK 465 THR C 14 REMARK 465 GLU C 15 REMARK 465 ASN C 16 REMARK 465 SER C 17 REMARK 465 SER C 18 REMARK 465 GLY C 31 REMARK 465 VAL C 32 REMARK 465 ASN C 33 REMARK 465 ASP C 34 REMARK 465 SER C 35 REMARK 465 PHE C 36 REMARK 465 PRO C 37 REMARK 465 ASP C 38 REMARK 465 GLY C 39 REMARK 465 ASP C 40 REMARK 465 TYR C 41 REMARK 465 GLY C 42 REMARK 465 ALA C 43 REMARK 465 GLY D 10 REMARK 465 PRO D 11 REMARK 465 THR D 12 REMARK 465 GLY D 13 REMARK 465 THR D 14 REMARK 465 GLU D 15 REMARK 465 ASN D 16 REMARK 465 SER D 17 REMARK 465 SER D 18 REMARK 465 GLY D 31 REMARK 465 VAL D 32 REMARK 465 ASN D 33 REMARK 465 ASP D 34 REMARK 465 SER D 35 REMARK 465 PHE D 36 REMARK 465 PRO D 37 REMARK 465 ASP D 38 REMARK 465 GLY D 39 REMARK 465 ASP D 40 REMARK 465 TYR D 41 REMARK 465 GLY D 42 REMARK 465 ALA D 43 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 213 -50.07 -138.63 REMARK 500 MET A 247 17.40 -141.75 REMARK 500 ARG A 263 43.07 -102.18 REMARK 500 TYR A 295 79.51 -100.75 REMARK 500 TRP A 375 -69.05 -98.86 REMARK 500 ALA A 463 45.08 -107.24 REMARK 500 ASN B 218 -69.10 -105.44 REMARK 500 THR B 232 -70.81 -66.99 REMARK 500 MET B 247 38.41 -140.49 REMARK 500 GLU B 320 -70.07 -80.56 REMARK 500 LYS B 370 71.33 43.41 REMARK 500 LYS B 428 -35.40 -138.74 REMARK 500 ALA B 469 93.05 -69.27 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN C OF DUFFY REMARK 800 ANTIGEN/CHEMOKINE RECEPTOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF DUFFY REMARK 800 ANTIGEN/CHEMOKINE RECEPTOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NUU RELATED DB: PDB REMARK 900 HETEROTRIMER STRUCTURE OF REGION II FROM PLASMODIUM VIVAX DUFFY REMARK 900 BINDING PROTEIN (PVDBP) BOUND TO THE ECTODOMAIN OF THE DUFFY REMARK 900 ANTIGEN RECEPTOR FOR CHEMOKINES (DARC) DBREF 4NUV A 211 525 UNP P22290 PVDR_PLAVS 211 525 DBREF 4NUV B 211 525 UNP P22290 PVDR_PLAVS 211 525 DBREF 4NUV C 14 43 UNP Q16570 ACKR1_HUMAN 14 43 DBREF 4NUV D 14 43 UNP Q16570 ACKR1_HUMAN 14 43 SEQADV 4NUV ALA A 209 UNP P22290 EXPRESSION TAG SEQADV 4NUV SER A 210 UNP P22290 EXPRESSION TAG SEQADV 4NUV ALA B 209 UNP P22290 EXPRESSION TAG SEQADV 4NUV SER B 210 UNP P22290 EXPRESSION TAG SEQADV 4NUV GLY C 10 UNP Q16570 EXPRESSION TAG SEQADV 4NUV PRO C 11 UNP Q16570 EXPRESSION TAG SEQADV 4NUV THR C 12 UNP Q16570 EXPRESSION TAG SEQADV 4NUV GLY C 13 UNP Q16570 EXPRESSION TAG SEQADV 4NUV GLY D 10 UNP Q16570 EXPRESSION TAG SEQADV 4NUV PRO D 11 UNP Q16570 EXPRESSION TAG SEQADV 4NUV THR D 12 UNP Q16570 EXPRESSION TAG SEQADV 4NUV GLY D 13 UNP Q16570 EXPRESSION TAG SEQRES 1 A 317 ALA SER ASN THR VAL MET LYS ASN CYS ASN TYR LYS ARG SEQRES 2 A 317 LYS ARG ARG GLU ARG ASP TRP ASP CYS ASN THR LYS LYS SEQRES 3 A 317 ASP VAL CYS ILE PRO ASP ARG ARG TYR GLN LEU CYS MET SEQRES 4 A 317 LYS GLU LEU THR ASN LEU VAL ASN ASN THR ASP THR ASN SEQRES 5 A 317 PHE HIS ARG ASP ILE THR PHE ARG LYS LEU TYR LEU LYS SEQRES 6 A 317 ARG LYS LEU ILE TYR ASP ALA ALA VAL GLU GLY ASP LEU SEQRES 7 A 317 LEU LEU LYS LEU ASN ASN TYR ARG TYR ASN LYS ASP PHE SEQRES 8 A 317 CYS LYS ASP ILE ARG TRP SER LEU GLY ASP PHE GLY ASP SEQRES 9 A 317 ILE ILE MET GLY THR ASP MET GLU GLY ILE GLY TYR SER SEQRES 10 A 317 LYS VAL VAL GLU ASN ASN LEU ARG SER ILE PHE GLY THR SEQRES 11 A 317 ASP GLU LYS ALA GLN GLN ARG ARG LYS GLN TRP TRP ASN SEQRES 12 A 317 GLU SER LYS ALA GLN ILE TRP THR ALA MET MET TYR SER SEQRES 13 A 317 VAL LYS LYS ARG LEU LYS GLY ASN PHE ILE TRP ILE CYS SEQRES 14 A 317 LYS LEU ASN VAL ALA VAL ASN ILE GLU PRO GLN ILE TYR SEQRES 15 A 317 ARG TRP ILE ARG GLU TRP GLY ARG ASP TYR VAL SER GLU SEQRES 16 A 317 LEU PRO THR GLU VAL GLN LYS LEU LYS GLU LYS CYS ASP SEQRES 17 A 317 GLY LYS ILE ASN TYR THR ASP LYS LYS VAL CYS LYS VAL SEQRES 18 A 317 PRO PRO CYS GLN ASN ALA CYS LYS SER TYR ASP GLN TRP SEQRES 19 A 317 ILE THR ARG LYS LYS ASN GLN TRP ASP VAL LEU SER ASN SEQRES 20 A 317 LYS PHE ILE SER VAL LYS ASN ALA GLU LYS VAL GLN THR SEQRES 21 A 317 ALA GLY ILE VAL THR PRO TYR ASP ILE LEU LYS GLN GLU SEQRES 22 A 317 LEU ASP GLU PHE ASN GLU VAL ALA PHE GLU ASN GLU ILE SEQRES 23 A 317 ASN LYS ARG ASP GLY ALA TYR ILE GLU LEU CYS VAL CYS SEQRES 24 A 317 SER VAL GLU GLU ALA LYS LYS ASN THR GLN GLU VAL VAL SEQRES 25 A 317 THR ASN VAL ASP ASN SEQRES 1 B 317 ALA SER ASN THR VAL MET LYS ASN CYS ASN TYR LYS ARG SEQRES 2 B 317 LYS ARG ARG GLU ARG ASP TRP ASP CYS ASN THR LYS LYS SEQRES 3 B 317 ASP VAL CYS ILE PRO ASP ARG ARG TYR GLN LEU CYS MET SEQRES 4 B 317 LYS GLU LEU THR ASN LEU VAL ASN ASN THR ASP THR ASN SEQRES 5 B 317 PHE HIS ARG ASP ILE THR PHE ARG LYS LEU TYR LEU LYS SEQRES 6 B 317 ARG LYS LEU ILE TYR ASP ALA ALA VAL GLU GLY ASP LEU SEQRES 7 B 317 LEU LEU LYS LEU ASN ASN TYR ARG TYR ASN LYS ASP PHE SEQRES 8 B 317 CYS LYS ASP ILE ARG TRP SER LEU GLY ASP PHE GLY ASP SEQRES 9 B 317 ILE ILE MET GLY THR ASP MET GLU GLY ILE GLY TYR SER SEQRES 10 B 317 LYS VAL VAL GLU ASN ASN LEU ARG SER ILE PHE GLY THR SEQRES 11 B 317 ASP GLU LYS ALA GLN GLN ARG ARG LYS GLN TRP TRP ASN SEQRES 12 B 317 GLU SER LYS ALA GLN ILE TRP THR ALA MET MET TYR SER SEQRES 13 B 317 VAL LYS LYS ARG LEU LYS GLY ASN PHE ILE TRP ILE CYS SEQRES 14 B 317 LYS LEU ASN VAL ALA VAL ASN ILE GLU PRO GLN ILE TYR SEQRES 15 B 317 ARG TRP ILE ARG GLU TRP GLY ARG ASP TYR VAL SER GLU SEQRES 16 B 317 LEU PRO THR GLU VAL GLN LYS LEU LYS GLU LYS CYS ASP SEQRES 17 B 317 GLY LYS ILE ASN TYR THR ASP LYS LYS VAL CYS LYS VAL SEQRES 18 B 317 PRO PRO CYS GLN ASN ALA CYS LYS SER TYR ASP GLN TRP SEQRES 19 B 317 ILE THR ARG LYS LYS ASN GLN TRP ASP VAL LEU SER ASN SEQRES 20 B 317 LYS PHE ILE SER VAL LYS ASN ALA GLU LYS VAL GLN THR SEQRES 21 B 317 ALA GLY ILE VAL THR PRO TYR ASP ILE LEU LYS GLN GLU SEQRES 22 B 317 LEU ASP GLU PHE ASN GLU VAL ALA PHE GLU ASN GLU ILE SEQRES 23 B 317 ASN LYS ARG ASP GLY ALA TYR ILE GLU LEU CYS VAL CYS SEQRES 24 B 317 SER VAL GLU GLU ALA LYS LYS ASN THR GLN GLU VAL VAL SEQRES 25 B 317 THR ASN VAL ASP ASN SEQRES 1 C 34 GLY PRO THR GLY THR GLU ASN SER SER GLN LEU ASP PHE SEQRES 2 C 34 GLU ASP VAL TRP ASN SER SER TYR GLY VAL ASN ASP SER SEQRES 3 C 34 PHE PRO ASP GLY ASP TYR GLY ALA SEQRES 1 D 34 GLY PRO THR GLY THR GLU ASN SER SER GLN LEU ASP PHE SEQRES 2 D 34 GLU ASP VAL TRP ASN SER SER TYR GLY VAL ASN ASP SER SEQRES 3 D 34 PHE PRO ASP GLY ASP TYR GLY ALA HET GOL A 601 14 HET GOL B 601 14 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 GOL 2(C3 H8 O3) FORMUL 7 HOH *52(H2 O) HELIX 1 1 MET A 214 ASN A 218 5 5 HELIX 2 2 PRO A 239 GLN A 244 1 6 HELIX 3 3 MET A 247 ASN A 252 1 6 HELIX 4 4 ASP A 264 LEU A 270 1 7 HELIX 5 5 LEU A 270 ASN A 291 1 22 HELIX 6 6 ASN A 296 MET A 315 1 20 HELIX 7 7 GLY A 323 GLY A 337 1 15 HELIX 8 8 LYS A 341 GLU A 352 1 12 HELIX 9 9 SER A 353 MET A 362 1 10 HELIX 10 10 MET A 362 LYS A 367 1 6 HELIX 11 11 LYS A 378 ASN A 384 1 7 HELIX 12 12 PRO A 387 ASP A 416 1 30 HELIX 13 13 LYS A 424 VAL A 429 1 6 HELIX 14 14 VAL A 429 ALA A 463 1 35 HELIX 15 15 THR A 473 LEU A 482 1 10 HELIX 16 16 ASN A 486 ASN A 495 1 10 HELIX 17 17 ASP A 498 VAL A 506 1 9 HELIX 18 18 MET B 214 ASN B 218 5 5 HELIX 19 19 PRO B 239 GLN B 244 1 6 HELIX 20 20 MET B 247 LEU B 253 1 7 HELIX 21 21 ASP B 264 ASN B 291 1 28 HELIX 22 22 ASN B 296 GLY B 316 1 21 HELIX 23 23 GLY B 323 GLY B 337 1 15 HELIX 24 24 LYS B 341 MET B 362 1 22 HELIX 25 25 MET B 362 LYS B 370 1 9 HELIX 26 26 GLY B 371 ILE B 376 5 6 HELIX 27 27 LYS B 378 VAL B 383 1 6 HELIX 28 28 PRO B 387 ASP B 416 1 30 HELIX 29 29 LYS B 424 LYS B 428 5 5 HELIX 30 30 VAL B 429 LYS B 461 1 33 HELIX 31 31 THR B 473 LEU B 482 1 10 HELIX 32 32 ASN B 486 ASN B 495 1 10 HELIX 33 33 ASP B 498 VAL B 506 1 9 HELIX 34 34 ASP C 21 SER C 29 1 9 HELIX 35 35 ASP D 21 SER D 29 1 9 SSBOND 1 CYS A 217 CYS A 246 1555 1555 2.03 SSBOND 2 CYS A 230 CYS A 237 1555 1555 2.03 SSBOND 3 CYS A 300 CYS A 377 1555 1555 2.03 SSBOND 4 CYS A 415 CYS A 432 1555 1555 2.03 SSBOND 5 CYS A 427 CYS A 507 1555 1555 2.03 SSBOND 6 CYS A 436 CYS A 505 1555 1555 2.04 SSBOND 7 CYS B 217 CYS B 246 1555 1555 2.03 SSBOND 8 CYS B 230 CYS B 237 1555 1555 2.04 SSBOND 9 CYS B 300 CYS B 377 1555 1555 2.03 SSBOND 10 CYS B 415 CYS B 432 1555 1555 2.04 SSBOND 11 CYS B 427 CYS B 507 1555 1555 2.03 SSBOND 12 CYS B 436 CYS B 505 1555 1555 2.04 SITE 1 AC1 3 ASN A 486 ALA A 489 GLU A 493 SITE 1 AC2 4 GLU B 484 PHE B 485 ASN B 486 GLU B 493 SITE 1 AC3 10 ARG A 274 ILE A 277 TYR A 278 ALA A 281 SITE 2 AC3 10 LYS A 289 GLN A 356 ALA A 360 TYR A 363 SITE 3 AC3 10 LYS A 366 ARG B 263 SITE 1 AC4 12 PHE A 261 ASP A 264 LYS B 273 ARG B 274 SITE 2 AC4 12 ILE B 277 TYR B 278 ALA B 281 LYS B 289 SITE 3 AC4 12 GLN B 356 TYR B 363 LYS B 366 LYS B 367 CRYST1 37.287 59.391 91.395 103.14 91.04 100.31 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026819 0.004878 0.001675 0.00000 SCALE2 0.000000 0.017114 0.004125 0.00000 SCALE3 0.000000 0.000000 0.011257 0.00000